Health Program

2007 Prescription Drug State Legislation

Updated February 8, 2008 - Subject to additions and regular updates during session months.

Introduction | Rx Summary - Table 1 | Rx Bills by State - Table 2 | Rx Resources

NEW: "2008 Prescription Drug State Legislation" - continues this 2007 report, with newly filed bills and actions specific to 2008. Updated frequently

The total U.S. spending on pharmaceuticals is projected to top $229 billion in 2007, while more than 40 percent of Americans take one or more prescription medications in a year. These facts help explain why, in 2007, prescription drug policies continue to attract widespread attention and action in state capitols. [1]

More than 500 pharmaceutical bills and resolutions were filed for consideration in 2007 legislative sessions. Two recent nationwide factors are affecting legislative directions this year. First, the federal Medicare prescription drug benefit now is in its second year, with more stability and fewer problems than last year. Second, a federal report released in February brought welcome news that the annual increase in pharmaceutical spending had dropped from double-digits three years ago to just 5.8 percent in 2006. That same report credited state and private sector actions with contributing to this economic change.

Proposed policies cover a wide range of state-sponsored approaches, from creation of subsidies or discount programs, to promoting safer pharmaceuticals and regulating the management, marketing and distribution of prescription products.

Map of 2007 Rx legislation

The following are examples of widespread or "hot" topics in 2007:

Expanding Access: Discount and Subsidy Programs -- A majority of states have established subsidy or discount programs to reduce prescription drug costs and provide direct relief to qualified low-income residents. In 2006, many states retooled their discount and subsidy programs to include Medicare Part D provisions; in 2007 proposed expansions and changes again are on the table in more than 20 states.
Picture- Rx pills in bottle

Marketing and Advertising -- A few states already require pharmaceutical manufacturers to disclose marketing expenses, including gifts to drug prescribers. During 2007, at least 27 states propose legislation requiring marketing disclosures by drug manufacturers, regulating direct-to-consumer advertising of prescription drugs by pharmaceutical companies or prohibiting prescription information from being sold for commercial purposes.

Privacy and "Data Mining" - In 2006 New Hampshire became the first state to prohibit the sale or redistribution of prescription sales record information that identified patients or prescribers. In 2007, at least 13 states have similar proposals, with laws signed in Maine and Vermont.

Medicare Part D Wrap Around Benefits and Services -- Although federal Medicare pharmaceutical plans appear more stable this year, 20+ states are considering bills and resolutions intended to modify or adjust state pharmaceutical assistance efforts, in response to the federal Medicare Prescription Drug benefit launched in January 2006. Most bills reference the Medicare Modernization Act or "MMA."

Pharmacy Benefit Managers (PBMs) -- At least 23 states have proposed legislation to regulate Pharmacy Benefit Management companies -- the middlemen who negotiate directly with manufacturers. The bills seek to assure financial reliability, regulate the licensing of pharmacy benefit managers and/or mandate full disclosure of drug costs and financial contracts.

Prescription Drug Reuse/Recycling -- Allowing or encouraging donation of unused pharmaceutical drugs is a popular idea - nine states passed such laws in 2006. For 2007 interest continues in 10 states, with some of the focus on cancer drug repository programs that allow an individual, health care facility or drug manufacturer to donate cancer drugs or supplies needed to administer cancer drugs for use by those who meet eligibility criteria.

Electronic Monitoring and Internet Prescribing -- This is a relatively recent trend which gained momentum during the past three years. Proposed laws would allow for the development and regulation of electronic transmission of prescription drug orders, as well as establishing Internet prescribing practices to provide increased protection for consumers purchasing prescription drugs over the Internet. Additionally, several more states seek to establish electronic prescription drug databases to monitor the misuse, abuse and diversion of prescription drugs and controlled substances. In August Alaska became the final state to change laws and regulations to allow for e-prescribing.

Other Topics of Interest -- Several states propose legislation to create bulk prescription drug purchasing or multi-state purchasing programs; others are considering bills to create prescription drug importation or re-importation programs. Bills providing for income tax deductions, incentives or credits for pharmaceuticals or prescription drug-related programs were proposed in some states. Cost containment also continues as a focus in some states, using measures to establish or modify preferred drug lists and seek manufacturer rebates or discounts. Other ideas, such as regulation of mail order prescription drug sales, oversight of pharmaceutical wholesalers, local pharmacy audits and publicizing clinical trials also are possible trends during 2007.

NCSL's separate 2006 Prescription Drug State Legislation online report includes all bills filed in 2006, including more than 90 resolutions and bills that became law in 30+ states.

2007 Laws and Enacted Resolutions: So far this year, laws have been passed and signed in these 42 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Dakota, Oregon, South Dakota, Phode Island, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming. In addition, the District of Columbia passed a 2007 bill in early 2008.
Non-binding resolutions have been adopted in Hawaii, Idaho, Kentucky and Texas.

This tracking report is designed to be updated regularly; future editions will include additional bills filed during the session year. The report generally does not include legislation regulating only pharmacists and pharmacies, nor measures solely affecting existing Medicaid plans. Topic codes listed for individual bills identify major topics, but may not include all provisions. Topic codes may include measures that would restrict, as well as expand, use of a particular policy.

Go to an individual state:
AL | AK | AZ | AR | CA | CO | CT | DE | FL | GA | HI | ID | IL | IN | IA | KS | KY | LA | ME | MD | MA | MI | MN | MS | MO | MT | NE | NH | NV | NJ | NM | NY | NC | ND | OH | OK | OR | PA | RI | SC | SD | TN | TX | UT | VT | VA | WA | WV | WI | WY |

TABLE 1: 2007 Rx Legislation Topic Summary

Prescription Drug Bill Major Topics	Topic Code	States with 2007 legislation [Subject to additions] (Bold = passed by legislature; underline = law)
Use of federal 340B discount price program	340B	AK, AR, CT, HI, KS, MA, NH, VT, WV
Access to brand name pharmaceutical products	Brand	FL, GA, ID, KY, LA, MI, MS, NY, PA, RI, TN, TX, UT, WA, WI
Multi-state or inter-agency bulk purchasing	Bulk	CO, CT, FL, HI, IN, MA, MI, MS, NH, NJ, NY, UT, VT, WV
Clearinghouse information	CL	CO, CT, HI, IL, LA, OK, TX
Discount program	D	CA, CO, HI, IL, IA, (MD), MA, MI, MN, NE, NV, NH, NJ, NY, OK, (OR). PA, RI, TN, TX, VA, WV, WI
Electronically transmitted prescription drug orders and electronic prescribing practices, including electronic monitoring	E	AL, AK, AZ, AR, CO, CT, FL, GA, IL, KY, LA, ME, MA, MN, MO, MT, NH, NJ, NY, OR, PA, SC, SD, TN, UT, VT, WA, WV
Generic drug use	Generic	CO, CT, FL, GA, LA, MA, MI, MS, NE, NJ, NM, NY, PA, RI, TN, VT
Regulate drug importation or reimportation	Imp	HI, KY, MA, MS, NY, OK, TN
Regulate Internet pharmacies (also see "Electronic" above)	Internet	AR, IL, LA, MA, NY, SC, TX, UT
Regulate forms, labels or packaging on retail Rx, including legibility	Label	AZ, CA, FL, GA, HI, IL, ME, MA,MI, NV, NY, OK, OR, SC, TN, TX, VA
Protect Rx manufacturers or providers from lawsuits	Liability	HI, MI, NY
Mail-order pharmaceuticals (also see PBM)	Mail	ID, MA, NH, NY, RI, SC, TN, TX, VT
Marketing & advertising (see www.ncsl.org/programs/health/rxads.htm for more information)	Mkt	AZ, CA, CT, FL, GA, HI, ID, IL, KS, ME, MD, MA, MS, MT, NE, NV, NH, NY, OH, OK, OR, RI, TN, TX, VT, WA, WV, WI
Medicaid (partial list; see notes)	M	AZ, CO, CT, FL, GA, HI, ID, IL, IN, IA, KS, LA, ME, MD, MA, MI, MN, MS, NE, NY, OK, OR, RI, TN, TX, UT, VT, WA, WV
Medicare Prescription Drug Act (MMA) state changes	MMA	AK, AZ, CA, CT, DE, FL, HI, ID, IL, KY, ME, MD, MA, MN, NJ, NY, OK, RI, TX, VA, WA, WV, WI
Regulation of pharmaceutical benefit managers	PBM	AR, CT, DE, GA, IL, IN, IA, KS, KY, ME, MD, MI, MN, MS, MO, NH, NY, ND, OK, SC, TN, TX, VT, VA, WA, WV
Preferred Drug List	PDL	CO, CT, DE, GA, HI, IN, LA, ME, MA, MN, MO, MS, NY, OK, OR, TN, TX, UT, VT, WV
Relates to pricing of pharmaceuticals	Price	AK, AR, CO, CT, FL, GA, HI, IL, IN, IA, KY, ME, MD, MA, MI, MN, MS, MO, NE, NH, NJ, NM, NV, NY, ND, RI, TX, VT, VA, WV, WI
Restricting sale or disclosure of Rx sales with patient or prescriber info.	Privacy	AZ, CA, (ID), IL, KS, (KY), ME, MD, MA, NV, NC, RI, TN, TX, VT, WA, WV
Reuse or recycling of pharmaceuticals	Reuse	AL, CO, IL, ME, MA, MN, MS, NM, NY, ND, OK, PA, RI, SC, TX, WI
State Rx Subsidy program	S	AK, AZ, CA, CT, DE, HI, IL, IN, ME, MD, MA, MN, NH, NJ, NY, PA, RI, VA, WA, WI
Study or task force on Rx	Study	AL, AR, AK, FL, IN, MD, NH, NY, OK, PA,
Income tax deductions, modifications, incentives or credits for pharmaceuticals or prescription drug-related programs	Tax	IL, LA, MD, MA, NY, VA, WA, WI
Disclose or regulate in-state Rx clinical trials	Trials	CA, HI, MS, NJ, NY, PA, RI
Regulate Rx wholesalers; preventing counterfeits	Whole	AL, AR, CO, GA, ID, IL, IA, KS, KY, MD, MA, MO, (MT), NV, NY, ND, OK, SD, TN, TX, UT, WA, WV, WI, WY
Other Rx policy	-	AL, AZ, AR, CA, CT, FL, HI, IL, ME, MD, MA, MS, MT, NE, NH, NM, NY, ND, PA, RI, SD, TX, WA

TABLE 2: 2007 Rx Legislation by State

Bills detailed in this table are subject to consideration during 2007 state legislative sessions. Two states, NJ & VA, allow for carry-over of 2006 bills into 2007. Because bill content and status change frequently, even daily, the bill status listed is simplified. For general schedules, see NCSL 2007 State Legislative Session Calendar

AL
HB 172
Rep. Johnson Would establish a committee of pharmacists to evaluate the performance of pharmaceutical care or pharmaceutical drug utilization review, provides good faith immunity for committee members.
(Filed 3/6/07; held in committee for final day, 6/7/07) | Study

AL
HB 174 Would allow the return of expired drugs to the distributor under certain conditions for credit or replacement.
(Filed 3/6/07; did not pass House committee 3/15/07) | Whole

AL
HB 213
Rep. Lindsey Would appropriate $1 million for the School of Pharmacy at Auburn Univ. "for biotechnical drug development and enhancing pharmaceutical science research leading to new drugs, complimentary to other biomedical research underway" in Alabama.
(Filed 3/07; passed House; passed Senate; signed into law by governor as Act 2007-361 6/7/07) Research, -

AL
HB 687 Would allow for the donation and reuse of prescription drugs and samples to charitable clinics under certain conditions.
(Filed 4/11/07; favorable report from committee 5/29/07) | Reuse

AL
HJR 349 Resolution would encourage the use of electronic transmission of prescriptions from doctor to pharmacy.
(Filed; died in committee 5/24/07) |
E

AK
HB 81
Rep. Guttenberg

Would establish the Alaska Prescription Drug Task Force to consider strategies to manage the costs of prescription drugs and to increase access to affordable prescription drugs for all state residents.
(Filed 1/16/07; did not pass by end of regular session 5/16/07) |*
Study

AK
HB 82
Rep. Guttenberg Would place requirements on pharmacies related to discount pricing including requiring that any 340B "covered entity
may not purchase a covered outpatient drug for a price that is higher thatn the 340B discounted price; requires the Department of Health and Social Services to conduct a study pertaining to prescription drug discounts and report the results to the legislature.
(Filed 1/16/07; did not pass by end of regular session 5/16/07) |* 340B, Price, Study

AK
HB 140,
SB 87
Rep. Gara
Would impose a beneficiary copayment of 20 percent for prescription drug costs and medical services covered under the Medicaid program for enrollees whose household income is between 250 and 350 percent of the federal poverty; would expand coverage for eligible children and pregnant women.
(Filed 1/5/07, 3/14/07; did not pass by end of regular session 5/16/07) |* M, Price

AK
HB 148,
SB 4
Sen. Olson Extends the Senior Care cash assistance program, but delete the existing stand-alone Rx wrap around benefit. Would providing payments of $250 a month for a senior who makes less than $9,578; $175 a month for a senior who makes between $9,578 and $12,770; $125 a month for a senior who makes between $12,770 and $22,348.
(Filed 1/07; HB 148 favorable committee report 3/12/07; did not pass by end of regular session 5/16/07)
(SB 4 passed Senate 14y-2n, 4/10/07; passed in special session 7/28/07; signed into law by governor as 1st Special Session. Chapter 1, 8/2/07 ) |
S, MMA

AZ
HB 2155
Rep. Stump
Allows for access to prescription drugs under declarations of emergency.
(Filed 1/24/07; passed House 57y-0n, 3/6/07; passed Senate 4/18/07; signed into law by governor as Chapter 207, 5/14/07) | Emerg

AZ
HB 2255
Rep. Stump Establishes a "continuous quality assurance program" to review pharmacy procedures for addressing pharmacy medication errors. Defines records as peer review documents not subject to use in arbitration or civil court proceedings.
(Filed 1/18/07; passed House 46y-9n, 2/19/07; passed Senate 16y-10n, 4/18/07; signed into law by governor as Chapter 121, 4/24/07) | E, Error,
Safety

AZ
HB 2256
Rep. Stump Would allow for medication therapy management (MTM).
(Filed and sent to committee 1/18/07; did not pass by end of regular session 4/18/07) | M, MTM

AZ
HB 2303 Would provides flexibility for hospitals that have pharmacy permits in purchasing and dispensing medicines.
(Filed 1/16/07; did not pass by end of regular session 4/18/07) | -

AZ
SB 1249
Sen. Johnson
Would require disclosure of all FDA recognized side effects be listed on a prescription for psychotropic medications.
(Filed and sent to committee 1/23/07; did not pass by end of regular session 4/18/07) | Label

AZ
SB 1401
Sen. Hale Would appropriate $332,000 to assist people with Medicare Part D copayments.
(Filed and sent to committee 1/25/07; did not pass by end of regular session 4/18/07) | MMA, S

AZ
SB 1518
Sen. Burton Cahill Would prohibit the sale of prescription information to third parties for a commercial purpose. Allows information to be sold or transferred for medical research and other defined reasons.
(Filed and sent to committee 1/29/07; did not pass by end of regular session 7/1/07) | Mkt, Privacy

AZ
SB 1519
Sen. Burton Cahill
Would require full disclose of prescription drug marketing costs and gifts to prescribers over $25. Provides for some exclusions for payments and reimbursement for expenses.
(Filed and sent to committee 1/30/07; did not pass by end of regular session 7/1/07) | Mkt

AZ
H B 2136
Rep. Stump Authorizes a controlled prescription drug monitoring program, including a computerized central tracking database.
(Substitute adopted, 3/16/07; passed House 6/20/07; passed Senate 5/10/07; sent to governor 6/21/07) |
Monitor, Safety

AR
SB 20
Sen. Altes
Would establish a prescription drug monitoring program.
(Filed 1/8/07; passed Senate 23y-7n, 3/8/07; died in House committee at end of session 5/1/07) |
E, Safety

AR
SB 189
Sen. Malone Prohibits the sale of online pharmaceuticals in Arkansas if the patient hasn't consulted a prescribing practitioner.
Filed 1/25/07; passed Senate; passed House; signed to law by governor as Act 128, 2/21/07) | Internet

AR
SB 895
Sen. Horn Would authorize a Legislative Task Force on Patient Choice to study regulating the dispensing of prescription drugs including "a system of support for physicians and dentists within a framework of safety and accountability," impact on patient choice and "an effective regulatory scheme that would protect the public safety and ensure accountability in the drug distribution system.
(Filed 3/5/07; passed Senate 3/21/07; passed House 97y-0n, 3/28/07; signed into law by governor as Act 720, 3/3/0/07) | Study, Whole

AR
SB 980
Sen. Horn Would eliminate the Joint Interim Committee on Health Insurance and Prescription Drugs.
(Filed, passed Senate 3/12/07; passed House 3/28/07; signed into law by governor as Act 731 3/30/07) | -

AR
HB 1821
Rep. Maxwell Would create the Arkansas Fair Trade Practices for Pharmacy Benefits Managers Act, to prohibit deceptive and unconscionable trade practices.
(Filed 2/23/07; died in committee at end of session 5/1/07) | PBM

AR
HB 2303
Rep. Wells
Would provide flexibility for hospitals that have pharmacy permits in the purchase and dispensing of prescriptions.
(Filed 3/1/07; died in committee at end of session 5/1/07) |
340B

AR
HB 2421
Rep. Wells Would allow a nonprofit, tax exempt, or governmentally funded hospital to obtain a pharmacy permit with certain limitations.
(Filed 3/1/07; died in committee at end of session 5/1/07) | 340B

AR
HB 2626
Rep. Sample
Provides for a "pharmacy audit bill of rights" using a state-regulated pharmacy audit process, including one week advance notice to pharmacies, requiring a pharmacist participate in clinical-related judgments, allowing use of hospital and doctor records to justify transactions, providing at least 30 days for administrative corrections and an appeal process.
(Filed and sent to committee 3/5/07; passed House 94y-6n, 3/19/07; passed Senate; signed into law by governor as Act 843, 4/3/07) |
Audit, Price

CA
AB 203 Relates to the California Discount Prescription Drug Program.
(passed Assembly; passed Senate; signed into law by governor as chapter 188, 8/24/07) D

CA
AB 851
Assm. Brownley Would require a pharmacist to include a large print informational insert with any dispensed prescription that poses substantial risk when taken in combination with alcohol or other medications, warning of the risks involved, as specified. Would impose a state-mandated local program.
(Filed 2/22/07; did not pass by end of regular session, 9/7/07; may be carried over to '08)* Label

CA
AB 1276
Assm. Carnett
Would eliminate the labeling requirement pertaining to the condition for which the drug was prescribed. Requires the container to be labeled with the intended purpose of the drug if indicated on prescription if the patient desires.
(Filed 2/26/07; did not pass committee, 4/24/07; may be carried over to '08)* Label

CA
AB 1399
Assm. Richardson
Would require a prescription drug label, upon request of a blind or visually impaired customer, to be readable by an assistive technology device for the blind or visually impaired.
(Filed 2/23/07; did not pass by end of regular session, 9/7/07; may be carried over to '08)*
Label

CA
AB 1587
Assm. De La Torre
SB 843
Sen. Calderon Would prohibit a provider of health care, a health care service plan, contractor, or corporation and its subsidiaries and affiliates from intentionally sharing, selling, using for marketing, or otherwise using any medical information, as defined, for any purpose not necessary to provide health care services to a patient.
(Filed; AB 1587 passed Assembly, 70y-6n, 5/27/07; did not pass Senate by end of regular session, 9/7/07; may be carried over to '08)* (SB 843 did not pass Senate by end of regular session, 9/7/07) Mkt, Privacy

CA
SB 400
Among other things, would require federally qualified health centers to use tamper resistant prescription pads for outpatient prescriptions.
(Filed 2/21/07 and sent to committee 9/11/07) Label

CA
SB 472
Sen. Corbett Adopts a standard format for the labeling of prescription drug containers dispensed in the state, that would include regulations for the font size of printed words on the label and the placement of information of the prescription and would provide that translated prescription drug labels should be made available to the patient if the patient's primary language is not English.
(Filed; passed Senate 5/29/07; passed Assembly 74y-4n, 9/5/07; signed into law by governor, 10/11/07, Chapter 470.) Label

CA
SB 606
Sen. Scott Would require a pharmaceutical company that sells, delivers, offers for sale, or gives away pharmaceutical drugs within the state to make publicly available the results of every completed clinical trial, except a phase 1 trial, for that drug, an explanation of noncompletion for any clinical trial that the company initiates or sponsors the initiation of, but does not complete, thus providing doctors and patients with additional information on the side effects and effectiveness of drugs.
(Filed 2/23/07; passed Senate 6/7/07; placed on inactive file; did not pass Assembly 9/6/07) | Trials

CA
SB 623
Sen. Wiggins Would provide that the Department of Health Care Services shall pay all copayments required by drug plans under the Medicare Program for generic or brand name medications for full-benefit dual eligible beneficiaries under specified conditions. Requires the department to develop a process for the reimbursement of Medi-Cal enrolled pharmacies for the cost of the copayments, unless specified conditions are met.
(Filed 2/22/07; did not pass committee by end of regular session, 9/7/07; may be carried over to '08)* MMA, S

CA
SB 966
Sen. Simitian Would require every retailer of pharmaceutical drugs to have in place a system for the acceptance and collection of pharmaceutical drugs for proper waste disposal.
(Filed; passed Senate; passed Assembly 45y-30n, 9/7/07; signed into law by governor as Chapter 542 of 2007, 10/12/07) | Safety, -

CA
AJR 31
Assm. Jones Would urge Congress to amend the Medicare Modernization Act of 2003 to require that the federal government negotiate for the lowest available prices for prescription drugs under the Medicare Part D program, eliminate a specified gap in Medicare Part D coverage, and reduce the lifetime penalty for late enrollment in the program.
(Filed 7/2/07, adopted by Assembly 8/27/07; did not pass Senate by end of session 9/7/07*) | MMA

CO
HB 07-1021
Rep. Frangas

Creates the prescription drug medication management program for Medicaid enrollees, providing information and technical assistance on "prudent use" of prescription drugs, avoiding drug interactions; also providing pharmacists who participate a financial incentive.
(Filed 1/10/07; passed House 2/23/07; passed Senate amended 4/25/07; signed into law by governor as Chapter 377, 5/31/07) |
CL, M

CO

HB 07-1070
Rep. Lundberg

Would repeal CO Unfair Practices Act, which provides it is against the law to sell something below market value. The intent relates to permitting discount programs to sell gasoline and generic drugs for $4 (such as those sponsored by Target, Wal-Mart and others.)
(Filed 1/07; postponed indefinitely, did not pass committee 2/8/07; see similar HB 07-1208, signed law below) |
Generic, Price

CO
HB 07-1208
Rep. Jahn
Modifies the CO Unfair Practice Act prohibiting selling products at below cost; the change makes it unlawful only for business to sell products below cost with intent to monopolize the market for the product; requires price calculation to be based on combined total prices, not single items. The intent relates to permitting discount programs to sell gasoline and generic drugs (such as the $4 prescription programs sponsored by Target, Wal-Mart and others.)
(Filed 1/07; amended and passed House 2/8/07; passed Senate 3/14/07; signed into law by governor 4/16/07) | Generic, Price

CO
SB 07-1

Sen. Hagedorn

Creates the Colorado Cares Rx program to provide generic and non-patented prescription drugs to eligible uninsured residents, with annual income up to 300 percent of federal poverty guidelines, at discounted prices negotiated by the state with manufacturers and pharmacies. The price to enrollees must be not less than AMP or actual cost and not more than WAC plus dispensing fee or the "customary charge" for the drug. Authorizes an application fee up to $20; will use voluntary participation by retail pharmacies. Appropriates $2.4 million for implementation.
(Filed 1/10/07, passed Senate 27y-6n, 1/26/07; passed House 57y-7n, 2/1/07; signed into law by governor 2/5/07) |
D

CO
SB 07-9
Sen. Tochtrop
Would transfer the Electronic Prescription Drug Monitoring Program to the Department of Public Health and Environment.
(Filed; postponed indefinitely, did not pass committee 2/7/07) | E, Monitor

CO
SB 07-204
Sen. Tochtrop

Creates a fee from prescribers of controlled substances as an optional funding source for the state's prescription drug monitoring program, aimed at preventing overuse or abuse; also appropriates up to $31,000 for annual program operations.
(Filed 2/27/07; passed Senate; passed House 4/27/07; signed into law by governor 5/22/07) |
E, Monitor

CO
SB 07-217
Sen. Boyd Regulates prescription drug wholesalers; including requiring criminal history background checks of applicant representatives, updating requirement for maintaining and retaining "pedigree" records to prevent or diversion to unauthorized buyers.
(Filed 3/6/07; passed Senate 4/2/07; passed House 4/12/07; signed into law by governor 5/25/07) Safety, Whole

CO
SB 07-231
Sen. Tochtrop
Repeals the State Board of Health's rule-making authority for the Cancer Drug Repository Program, and authorizes a pharmacist to make the determination related to which drugs and devices are safe and requires a health care facility, medical clinic, or pharmacy that participates in the program to establish the eligibility criteria.
(Filed; signed into law by governor 5/25/07)
Reuse

CO
EO 07-04
Gov. Ritter Based in part on SB06-01 passed in 2006, this Executive Order establishes a "preferred drug list for non-Medicare clients receiving drugs through the fee-for-service and primary care physician programs in the Colorado Medical Assistance Program." Requires the Department to "evaluate the various methods by which a PDL is implemented and maintained and shall determine the best option for Colorado’s PDL; also requires obtaining supplemental rebates and an evaluation of the feasibility and cost-effectiveness of entering into one of the existing multi-state purchasing pools.
(SB06-01 passed in 2006; signed by governor as Executive Order 1/31/07) | Bulk, M, PDL

CT
HB 5050
Rep. Witkos Would adjust ConnPACE to include physical examinations.
(Filed and sent to committee 1/3/07; did not pass before end of regular session) | S

CT
HB 5332
Rep. Janowski
Would increase access to chronic medication and makes their purchase more affordable by requiring insurance companies to cover 90 day supplies with one copay.
(Filed and sent to committee 1/11/07; did not pass before end of regular session) |
-

CT
HB 6893 Requires the Department of Social Services to establish a Communications and Outreach Program on long-term care and the Medicare Part D program, and "shall disseminate information to the public" about prescription drug benefits.
(Passed House; passed Senate; signed into law by governor as public Act 155, 6/25/07) CL, MMA

CT
SB 53
Sen. DeFronzo Would increase access to ConnPACE by allowing those with higher incomes to utilize the program at a graduated rate.
(Filed and sent to committee 1/3/07; did not pass before end of regular session) | S

CT
SB 57
Sen. Crisco
Would require the licensing of pharmacy benefit managers.
(Filed and sent to committee 1/3/07; did not pass before end of regular session) |
PBM

CT
SB 74
Sen. Crisco
Requires pharmacy benefit managers to obtain a certificate of registration from the Insurance Department before operating in Connecticut; applications require a list of people running the PBM, evidence of a surety bond of at least $25,000 and a $50 annual fee. Permits the insurance commissioner to suspend, revoke, or deny registration for specified causes after notice and hearing. PBMs must apply annually for registration renewal. PBMs run by an insurer, hospital or fraternal benefit society are exempt from registation requirements.
(Filed; passed Senate 6/4/07; passed House 6/6/07; signed into law by governor as Public Act 07-200)
PBM

CT
HB 5484
Rep. Schofield Would enable more seniors to qualify as Qualified Medicare Beneficiaries or Specified Low-Income Beneficiaries, thereby entitling such persons to the low-income subsidies available under the Medicare Part D program which in turn will reduce ConnPACE program expenditures by maximizing the number of ConnPACE enrollees who obtain federal low-income subsidies.
(Filed and sent to committee 1/16/07; did not pass before end of regular session) |
S

CT
HB 5507
Rep. O'Brien Would establish a prescription drug bulk purchasing program and lower prescription drug costs through bulk purchasing.
(Filed and sent to committee 1/16/07; did not pass before end of regular session) | Bulk

CT
HB 5632,
HB 5646
Rep. O'Brien,
Rep. Taborsak Would expand ConnPACE eligibility to more seniors and persons with disabilities.
(Filed and sent to committee 1/17/07; did not pass before end of regular session) | S

CT
HB 5668
Rep. Lopez Kirkley-Bey Would require health insurers to charge the same copayment for each prescription, regardless of whether the prescription is for thirty, sixty or ninety days, provided the entire prescription is purchased at one time.
(Filed and sent to committee 1/17/07; did not pass before end of regular session) | -

CT
HB 6330
Rep. Olson Would make an appropriation for a community health access management program and provide funding for the establishment of a program to connect uninsured and underinsured residents of CT to affordable health care, prescription medications and community resources.
(Filed and sent to committee 1/19/07; did not pass before end of regular session) | CL

CT
HB 6627
Rep. O'Brien
Would establish maximum wholesale prices for prescription drugs; regulates wholesale prices for prescription drugs sold to local pharmacies in order to lower the cost for consumers.
(Filed and sent to committee 1/22/07; did not pass before end of regular session) |
Price

CT
HB 6893
Rep. O'Neill
Would establish a Communications and Outreach Program on long-term care and the Medicare Part D program.
(Filed 1/24/07; passed House 5/24/07; passed Senate 6/4/07 and signed into law by governor as Public Act 07-155)
MMA

CT
HB 7131 Would expand ConnPACE program eligibility to more residents.
(Filed and reported out of legislative commissioner's office on 3/2/07; did not pass before end of regular session)| S

CT
HB 7324 Would reimburse pharmacists for revenues lost due to new federal upper limits on Medicaid payments for generic drugs.
(Filed and sent to committee 3/2/07; did not pass before end of regular session) | M, Generic

CT
SB 1, SB 3
Sen. Williams
Would require, as part of the Husky Kids program, that each federally qualified health center participating in the program enroll in the federal Office of Pharmacy Affairs 340B drug discount program; deletes a 2003 deadline.
(Filed and sent to committee 2/07; did not pass before end of regular session) |
340B

CT
SB 147
Human Services Committee Would require the Commissioner of Social Services to implement measures that ensure that the department's prescription drug program beneficiaries are not being denied access to needed prescription drugs due to the implementation of prior authorization requirements or the utilization of preferred drug lists.
(Filed and sent to legislative commissioner's office 3/1/07; did not pass before end of regular session)| PDL, M

CT
SB 1189
Would require pharmaceutical manufacturing companies to report incentives given to prescribers.
(Filed and sent to committee 2/14/07; did not pass before end of regular session) |
Mkt

CT
SB 1228 Would authorize the dispensing of prescriptions contained in a common database under specified conditions.
(Filed and sent to committee 2/20/07; did not pass before end of regular session) | Safety

CT
SB 1229
Rep. Beldin
Would authorize pharmacies to utilize electronic prescriptions.
(Filed and sent to legislative commissioner's office 3/6/07; did not pass before end of regular session) |
E

DE
HB 105
Rep. Maier Would establish standards and criteria for the regulation, solvency and licensing of Pharmacy Benefit Managers.
(Filed and sent to committee 3/29/07) PBM

DE
HB 250
Rep. Oberle Requires the state to establish a drug rebate process for any prescription benefits provided to clients enrolled in the non-Medicaid programs administered by the division including the Delaware Healthy Children program, the Renal Disease program, the Delaware Prescription Assistance program and the Legal Non-Citizen Health programs.
(Filed; passed House and Senate; signed into law by governor as Chapter 80, 7/1/07) PDL, S

DE
HJR 15
Rep. Miro Joint resolution would direct the Secretary of the Delaware Department of Health and Social Services to perform a fiscal impact analysis to determine how much revenue Delaware pharmacies are expected to lose because of Medicaid's new formula that determines maximum reimbursement for multiple-source drugs, and directs the state to adopt emergency final regulations that increase the amount of reimbursement.
(Filed and passed House 37y-0n, 6/30/07; carried over to '08; sent to Senate committee 1/9/08) M, Price

DE
SB 11
Sen. McBride Amends the current DPAP law by providing an exception and additional opportunity for new DPAP applicants to obtain prescription drug coverage through DPAP while the applicant pursues Medicare Part D enrollment.
(Filed; passed Senate 3/20; passed House 4/4/07; signed into law by governor as Chapter 7, 4/5/07 ) MMA, S

DC
B17-0364
Councilman Catania,
The SafeRx Act would make the District the first in the nation to require licensing of pharmaceutical representatives and impose penalties for misleading remarks made in sales pitches to doctors. The goal is to counteract the influence that the pharmaceutical "detailers." Also would ban drug-company representatives from buying meals for physicians and giving them small gifts branded with the names of drugs or pharmaceutical companies. Reps would still be allowed to give doctors drug samples.
Deleted from final bill: prohibiting pharmaceutical representatives from data mining, or using area prescribing data and trends as a marketing tool to target specific physicians.
News article: "D.C. Council votes to regulate pharmaceutical reps" Washington Business Journal 11/23/07.
(Filed 9/29/07; passed City Council 7y-6n, 1/8/08; signed into law by mayor as Act A17-0282, 2/1/08; requires review by US Congress)
Mkt

Privacy

FL
HB 565 Would rename the Medicaid Pharmaceuticals and Therapeutics committee.
(Filed 3/6/07; died in committee 5/4/07) | M

FL
HB 893 Would prohibit the sale, manufacture, alteration, delivering, or possession of counterfeit-resistant prescription blanks for controlled substances.
(Filed 3/6/07; died in committee 5/4/07 but substituted with H 1155 below ) | Label

FL
HB 895
Would exempt from public records electronic prescription records for controlled substances; would allow for legitimate uses.
(Filed and sent to committee 2/23/07; died in committee 5/4/07) |
E

FL
SB 268 Would mandate the coverage of psychotropic medications when medically necessary.
(Filed 3/6/07; died in committee 5/4/07) | -

FL
HB 1155
Would prohibit sale, manufacture, alteration, delivery, uttering, or possession of counterfeit-resistant prescription blanks for controlled substances with intent to injure or defraud; specifies circumstances under which pharmacist who dispenses controlled substances by mail is exempt from certain requirements governing patient ID.
(Filed 2/27/07; passed House 4/30/07; passed Senate 5/3/07; signed into law by governor 6/15/07 as 2007-156)
Label

FL
SB 284
Would provide legislative intent to support development of FDA-recognized botanical drugs from patented complexes that "enhance effects of vaccines, helps suppress cancerous tumors and improves functioning of the human immune system;" summarizes testing procedures.
(Filed 3/6/07l died in committee 5/4/07) | Brand, Research

FL
SB 518
Would prohibit sale, manufacture, alteration, delivery or possession of counterfeit-resistant prescription blanks for controlled substances; provides additional requirements for dispensing of said substance listed in Schedule II, III, or IV; provides requirements and limitations for dispensing said substances upon oral prescription; prohibits using funds from Medical Quality Assurance Trust Fund to administer.
(Filed and sent to committee 3/6/07; died but substituted HB 1155 above) | Label

FL
SB 520
Would exempt from public-records requirements information and records reported to the Department of Health under electronic monitoring system for prescription of controlled substances listed in Schedules II-IV; authorizes certain persons and entities access to patient-identifying information; provides guidelines for use of such information and penalties for violations; provides for future legislative review and repeal.
(Filed and sent to committee 3/6/07; died in committee 5/4/07) |
Mkt

FL
SB 610
Would urge US Congress to support the Medicare Prescription Drug Price Negotiation Act of 2007 and allow for federal negotiation of Medicare Part D drug prices.
(Filed and 3/6/07; died in committee 5/4/07) | MMA, Price

FL
SB 2146
Would require the state to join the multistate purchasing pool for Medicaid products. Also would require the Dept. of Elderly Affairs to study the effects of Medicare Part D benefits on Medicare enrollees.
(Filed 2/26/07; died in committee 5/4/07) | Bulk, M, MMA, Study

FL
SB 2830 Would allow that patients have the right to choose between generic or branded prescriptions.
(Filed 3/5/07; died in committee 5/4/07) | Generic, Brand

GA
HB 18
Rep. Stephens Would require refund of Rx rebates from manufacturers and repeal conflicting laws.
(Prefiled 12/7/06; no further action before end of session) | M

GA
HB 19
Rep. Stephens Would require disclosure and refund of any Rx rebates from manufacturers that contract with the state.
(Prefiled 12/7/06; no further action before end of session) | M

GA
HB 45
Rep. Stephens
Would prohibit prior authorization for a prescription drug which a drug manufacturer provides to a community pharmacy at the lowest price of a pricing structure.
(Filed and sent to committee 1/11/07; no further action before end of session) |
Brand, PDL, Price

GA
HB 127
Rep. Byrd Would provide that a patient may instruct a pharmacist not to substitute a generic name drug in lieu of a brand name drug.
(Filed and sent to committee 1/24/07; passed House 3/1/07; Senate favorable report 3/28/07; no further action before end of session) | Brand, Generic

GA
HB 285
Would require an ID to be shown prior to dispensing a controlled substance.
(Filed and sent to committee 2/8/07; no further action before end of session) |
Safety

GA
HB 367
Rep. Carter Would allow health insurance coverage for therapeutically equivalent substitutions in certain situations.
(Filed and sent to committee 2/10/07; no further action before end of session) | Generic, Brand

GA
HB 454
Rep. Gardner
Would require pharmacists to include the approximate retail price for an outpatient drug on the receipt for that product and repeal conflicting laws.
(Filed and sent to committee 2/14/07; no further action before end of session) |
Price

GA
HB 455
Rep. Stephens Would enact the Georgia Prescription Monitoring Program Act to monitor dispensing of schedules II-IV.
(Filed and sent to committee 2/15/07; no further action before end of session) | E

GA
HB 180
Rep. Rogers Would allow that certain prescription drugs and other health care products sold by Georgia biotechnology, biopharmaceutical, or pharmaceutical companies not be subject to certain prior authorization or supplemental rebates for purposes of coverage under the state health benefit plan, medical assistance program, PeachCare for Kids, or any other health benefit plan or policy administered.
(Filed and sent to committee 1/26/07; no further action before end of session) | Brand, M
PDL

GA
HB 550
Rep. Lindsey Would expand certain obligations of insurers, managed health care entities, and pharmacy benefit managers.
(Filed 2/27/07; favorable committee report 3/19/07; House withdrawn, recommitted; no further action before end of session) | PBM

GA
HB 556
Rep. Benton Would require the prescriber's name to be printed on a prescription below his or her signature for controlled substances.
(Filed and sent to committee 2/27/07; no further action before end of session) | Label

GA
SB 28
Sen. Hill
Would require pharmacies to submit comparative price information, to be posted on a state sponsored website.
(Filed and sent to committee 1/22/07; no further action before end of session) |
Disclose, Post, Price

GA
SB 129
Sen. Grant Would allow limited copayments by inmates for prescription medications. Amount of copayment is not specified, but would not apply to inmates without funds in a prison account.
(Filed and sent to committee 2/10/07; no further action before end of session) | Copay

GA
SB 150
Sen. Hill Would provide for creation of a state website, including prescription drugs for which price information shall be collected. Such information shall include recent average wholesale prices and retail prices. If a prescription drug is available in a generic form, price data shall be reported for the generic drug and its brand name equivalent.
(Filed and sent to committee 2/13/07; no further action before end of session) | Price, Disclose

GA
SB 178
Sen. Balfour
Would allow for mail order prescription sales under regulated conditions.
(Filed 2/20/07; passed Senate 3/20/07; withdrawn, did not pass House committee 4/2/07) |
Mail

GA
SB 205
Sen. Thomas Enacts the "Prescription Medication Integrity Act" to provide for pedigrees for prescription drugs.
(Filed 2/27/07; passed Senate 3/28/07; passed House 4/19/07; signed into law by governor as Act 245, 5/24/07) Safety, Whole

GA
SB 294
Sen. Murphy Would change the criteria for substituting generic drugs for brand name drugs.
(Filed and sent to committee 3/1/07; no further action before end of session) | Generic, Brand

HI
HR 34
HCR 54
Rep. Yamashita Creates a task force to review the state's maximum allowable cost (MAC) program's reimbursement policy and its impact on community pharmacies.
(HR 34 Filed 3/2/07; final adopted in House, 4/12/07)
(HCR 54 filed 3/2/07; adopted by House 4/12/07; in Senate 4/24/07) M, Price

HI
HB 6,
SB 817
Rep. Takumi
Would require quarterly reports that disclose the average wholesale price, wholesale acquisition cost, average manufacturer price, and best price for each of the manufacturer's drugs from manufacturers of certain prescription drugs dispensed.
(Filed 1/22/07; deferred in House committee 1/29/07) | M, Price, Mkt

HI
HB 7,
SB 817
Rep. Takumi Would direct the governor to establish the State of Hawaii's participation in the I-SaveRx prescription drug program to provide residents with increased access to affordable drugs; relates to prescription drugs.
(Filed and sent to committee 1/25/07; deleted from agenda 2/9/07) | D, Imp

HI
HB 8, SB 819
Rep. Takumi Would allow consumers, the State, and other affected parties to obtain an injunction, damages, and other relief when a drug manufacturer or its licensee sells prescription drugs for an excessive price.
(Filed 1/22/07; deferred in House committee 1/29/07) | Liability, Price

HI
HB 9
SB 822
Rep. Takumi
Would prohibit the sale or transfer of patient prescription information by certain businesses as an unfair and deceptive act in the conduct of trade or commerce.
HB 9 (Filed and sent to committee 1/22/07 and deferred in House Committee) |
SB 822 (Filed and held in committee 2/6/07) |
Mkt

HI
HB 10,
SB 811
Rep. Takumi, Sen Igo
Modifies the Rx Plus state discount program and Medicaid, mandating rebate agreements between drug manufacturers and Department of Human Services using "best efforts to obtain a rebate amount equal to or greater than the amount of any discount, rebate, or price reduction for prescription drugs provided to the federal government," also requiring the Department to inform health care providers about drug costs for manufacturers with rebate agreements and those without rebate agreements.
Filed, HB 10 passed House 3/1/07; amended; passed Senate 4/10/07; vetoed by governor 4/27/07; House override 46y-3n; Senate override 18y-4n; became law by veto override as Act 60, 5/3/07) D, M, PDL, Price

HI
HB 11
SB 814
Rep. Takumi
Would require prescription drug advertisements to meet Federal standards, public disclosure of clinical trial information, and drug manufacturers to pay fees to Department of Health to fund a public education initiative on clinical trials and drug safety.
(Filed and sent to committee 1/22/07; deferred by committee 2/2/07) |
Trials

HI
HB 12
Rep. Takumi Would require the Director of Human Services to establish a pharmacy best practices and cost control program, including Medicaid and other state public assistance health benefits plans, in which any public and private health plan may participate; includes a prescription drug preferred list and prior authorization review process.
(Filed and sent to committee 1/25/07; deferred by committee 2/7/07) | Bulk, M, PDL

HI
HB 370,
SB 232
Rep. Lee Would establish remote dispensing pharmacy regulations.
(Filed and referred by committee 1/22/07) | -

HI
HB 817,
SB 1195
Rep. Mizuno Would appropriate funds for the Sage PLUS program, which provides assistance at no charge to people receiving Medicare and Medicaid benefits and near-retirees, to expand services to the neighbor islands and to support the program's operating costs. House amended effective date to July 2020.
HB 817 (Filed, passed House and sent to Senate 3/6/07; referred by committee 3/23/07) |
SB 1195 (Filed, sent and referred by committee 2/15/07) | MMA, CL

HI
HB 1321,
SB 1407
Rep. Say Would establish licensing and solvency requirements for prescription drug plans that are offering a pharmacy benefit pursuant to Medicare Part D.
HB 1321 (Filed, sent to and referred by committee 1/24/07) |
SB 1407 (Filed sent to and referred by committee 2/16/07) | MMA

HI
HB 1359
SB 1445
Rep. Say
Would create a Hawaii State Pharmacy Assistance program by merging the current State Pharmacy Assistance program which coordinates the Medicare Part D drug benefit and the Hawaii Rx Plus program under a single comprehensive Hawaii State Pharmacy Assistance program umbrella. Would allow 340B qualified entities to use telepharmacy if there is no other pharmacy within 5 miles.
HB 1359 (Filed, passed House 3/6/07; passed Senate 25y-0n & sent to conference comm, 4/10/07) D, MMA, S, M, 340B, PDL.

HI
HB 1478
SB 1729
Rep. Green Would extend income eligibility requirement to 200% of the federal poverty level; Would require the department to provide enrollees with counseling about prescription drug plans; would repeal prescription drug rebate funding limitations; relates to state pharmacy assistance program.
HB 1478 (Filed and sent to committees 1/24/07, 2/16/07) D, S

HI
SB 257 Would prohibit pre-signed and predated prescriptions.
(Filed, passed Senate 3/6/07; deferred by House committee 3/22/07) | Label

HI
SB 816
Sen. Ige
Would require the Director of Human Services to establish a pharmacy best practices and cost control program including Medicaid and other state public assistance health benefits plans, in which any public and private health plan may participate; includes a prescription drug preferred list and prior authorization review process; requires drug manufacturers to disclose economic benefits of $25 or more provided to persons who prescribe, dispense, or purchase prescriptions.
(Filed, passed Senate 3/6/07; amended, deferred by House committee 3/29/07) |
Mkt, PDL,

ID
HB 158
Health & Welfare Amends existing law relating to patient medical information and prescription confidentiality to provide that disclosure of patient specific information to law enforcement authorities is not prohibited if made pursuant to a search warrant, subpoena or other court order. Effective 7/1/07.
(Filed 2/9/07; passed House 67y-0n; passed Senate 34y-0n, 3/13/07; signed into law by governor as Chapter 140, 3/21/07) Privacy

ID
HB 164
Health & Welfare
Would allow mail order pharmacies to reduce the number of days per week they must provide toll-free phone service for purposes of customer service and patient communication.
(Filed; both passed House 67y-0n, 2/26/07; did not pass Senate 4/11/07) |
Mail

ID
SB 1146
Would change existing law relating to wholesale drug distribution to provide a short title; to require licensure of wholesale drug distributors; to provide for licensing requirements; to provide for limitation on disclosure of information; to provide restrictions on transactions; to require each person who is engaged in wholesale distribution of prescription drugs to provide a pedigree.
(Filed and sent to committee 2/12/07; did not pass Senate 4/11/07) | Whole

ID
SB 1184
Judiciary and Rules Comm. Requires state licensure of drug wholesalers and requires a product pedigree including detailed recordkeeping .
(Filed 3/1/07; passed Senate 31y-4n, 3/8/09; passed House; signed into law by governor as Chapter 319, 3/30/07) | Whole

ID
HJM 1
Non-binding memorial requesting the U.S. Secretary of Health and Human Services to amend, if not eliminate, the Phased-Down State Contribution or "clawback" payments relating to pharmacy benefits for Medicare and Medicaid programs.
(Filed and adopted by House and Senate 2/26/07) | M, MMA

ID
SJM 104
Sen. Werk Non-binding memorial stating findings of the Legislature and requesting the Congress of the United States to enact legislation requiring specific content for prescription drug advertising with name-brand drug identifications.
(Filed and sent to committee 2/12/07; did not pass Senate 4/11/07) | Mkt

IL
HB 157
HB 301
HB 1513 Would amend the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act. Provides for an annual increase in the household income amounts used to determine eligibility for a grant, the increase being equal to the cost-of-living increase designated under the federal Social Security Act.
(Filed and sent to committee 3/23/07; did not pass before end of session) | S, Tax

IL
HB 732 Would establish a pilot program in Kane County to provide funding for and coordination of specialty health care services, pharmaceutical drug assistance, and diagnostic testing for individuals who are not eligible for medical assistance under the Illinois Public Aid Code and who do not have other health insurance coverage.
(Filed and sent to committee 2/7/07, passed House 3/2/07, passed Senate 5/16/07 and sent to governor; Amendatory Veto by governor 8/13/07, may be subject to further legislative action*) | D

IL
HB 691 Would state that prescribers may not prescribe medications for patients via the Internet, WWW, phone or fax unless the patient has been physically examined by the prescriber or has been given a documented patient evaluation, including any medical history and physical exam for the condition prescribed.
(Filed and sent to committee 2/8/07; passed House 3/28/07 and sent to Senate; did not pass before end of '07 session*) | E, Internet

IL
HB 813
Would establish a cancer drug repository program to which people may donate cancer drugs or supplies to be used by individuals who meet criteria set by the Department of Health. Also sets forth requirements that cancer drugs or supplies must meet in order to be accepted and dispensed under the program.
(Filed and sent to committee 2/7/07; passed House 3/21/07; no further action before end of '07 session*) |
Reuse

IL
SB 86
HB 3601 Would amend the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act and increase the household income eligibility limitations for grant year 2007, and provides that, for grant years 2008 and thereafter, the limitations shall be increased annually by the percentage increase in the Consumer Price Index for the previous calendar year.
(Filed and sent to committee 1/31/07; did not pass before end of session) | Price, Disclose

IL
HB 872 Would create a Prescription Drug Ethical Marketing Act that would require every manufacturer and labeler in the state to disclose the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional activities by the company, directly or through its pharmaceutical marketers, to any physician, or any other prescriber in the state.
(Filed and sent to committee 2/7/07; dic not pass before end of session) | Mkt

IL
HB 1082 Would create the online clearinghouse to be known as the State of Illinois Prescription Drug Price Finder to provide a Drug Price that identifies the 50 most commonly prescribed drugs in Illinois and their usual and customary prices.
(Filed and sent to committee 2/8/2007; passed House 3/22/07; postponed in Senate; did not pass before end of session) | CL, Price

IL
HB 1248 Would allow the symptom to be put on the prescription bottle label.
(Filed and sent to committee 2/9/07; did not pass before end of session) | Label

IL
H 1257
Rep. Feigenholtz Amends the Pharmaceutical Assistance Act. Provides for beneficiaries who have a diagnosis of HIV or AIDS. Provides for covered prescription drugs by the Medicare Part D Prescription Drug Plan in which the beneficiary is enrolled.
(Filed; passed House; passed Senate; signed into law by governor as Public Act 95-208, 8/16/07) S

IL
HB 1459 Would amend existing code and law to prohibit the licensure, transfer, use or sale of any records relative to prescription information containing patient-identifiable or prescriber-identifiable data by any licensee or registrant of the Acts for commercial purposes.
(Filed and sent to committee 2/21/07; did not pass before end of session) | Privacy, Mkt

IL
HB 1461 Amends pharmaceutical assistance programs so that covered prescription drugs includes any agent or drug added by the Department of Healthcare and Family Services within the therapeutic categories of antipsychotics, antidepressants, and anticonvulsants.
(Filed and sent to committee 2/21/07; did not pass before end of session) | M

IL
HB 3005
Would make a technical change in a Section concerning pharmacy payments under the Medicaid program.
(Filed and sent to committee 2/26/07; did not pass before end of session) | M

IL
HB 3689 Would amend the wholesale drug distribution licensing procedure.
(Filed and sent to committee 3/1/07; did not pass before end of session)| Whole

IL
SB 30 Would establish an electronic monitoring program for schedules II, III, IV and V controlled substances.
(Filed and sent to committee 2/7/07; passed Senate 5/30/07; passed House 5/30/07; signed into law by governor as Public Act No. 95-442, 6/28/07)| E

IL
SB 509 Would create a whole licensure and prescription medication integrity act. Would mandate licensure for wholesalers and those that ship Rx into the state.
(Filed and sent to committee 2/8/07; passed Senate 5/8/07; final action deadline extended for House until 7/31/07 on 6/30/07) | Whole

IL
SB 595
Sen. Koehler
Creates a program in the Dept. of Aging to help those over age 60 with managing their medications.
(Filed 2/8/07; passed both chambers 5/31/07; signed into law by governor as Public Act 95-0535, 8/28/07) | Safety, -

IL
SB 705
Makes it illegal to alter a prescription or possess blank prescription pads without the permission of prescriber, and attempt to fill prescriptions that are from an unauthorized prescriber.
(Filed 2/8/07, amended by committee; passed both chambers 5/31/07; signed into law by governor as Public Act 95-0487, 8/28/07)
Label

IL
SB 726 Would allow the cost of a prescription reading machine or machine that makes audible prescription labels to be tax deductible.
(Filed and sent to committee 2/8/07; no further action before end of session) |* Tax

IL
HB 915, HB 948,
HB 1089, HB 1176,
HB 2581, HB 2988,
HB 2989, HB 2990,
SB 86, SB 524,
SB 1195

Would amend the state Pharmaceutical Assistance programs (SPAP) by adjusting enrollee benefits and eligibility, including wrap around benefits tied to Medicare Part D.
(All filed and sent to committees 2/07; none had further action before end of session) |*
D, MMA, S, Tax

IL
SB 1518
Would require PBMs or other parties that contract with the state to be legally responsible for payment of a health care claim.
(Filed and sent to committee 2/9/07; passed Senate 3/21/07 and sent to House; no further action before end of sesison) |*
PBM

IL
SB 147 Would create the Pharmaceutical Best Price Buying Initiative Act and amends the Freedom of Information Act and the Illinois Public Aid Code. Creates the Pharmaceutical Best Price Buying Initiative Program. Requires the Department of Healthcare and Family Services to negotiate prescription drug discount agreements with drug manufacturers to provide discounts for drugs purchased by pharmacies and drug wholesalers participating in the program.
(Filed and sent to committee 1/31/07; did not pass out of committee by end of session) |* D, Price

IN
HR 87
Would create an interim committee to study Pharmacy Benefit Managers.
(Filed 4/27/07)
PBM, Study

IN
H 1001 FY08 budget would appropriate $7.9 million for the IN Prescription Drug Program.
(Filed; passed House 4/29/07; passed Senate 4/30/07; signed into law by governor 5/11/07) | S

IN
HB 1008 Among other things, would provide for an aggregate prescription drug purchasing plan for state employees.
(Filed and sent to committee 2/23/07; did not pass out of committee by end of session) | Bulk

IN
HB 1390 Would create requirements that apply to a pharmacy benefit manager; makes a violation of the requirements an unfair and deceptive act or practice in the business of insurance.
(Filed and sent to committee 1/16/07; did not pass out of committee by end of session) | PBM

IN
HB 1584 Would allow a practitioner to deliver to a patient through a community or migrant health center or maternal and child health clinic a drug sample that is not more than five years past the expiration date.
(Filed and sent to committee 1/23/07; did not pass out of committee by end of session) | Sample

IN
HB 1642
Would require the office of Medicaid policy and planning to adjust prescription dispensing fees based on a survey of pharmacy